MELD3.0 is superior to MELDNa and MELD for prediction of mortality in patients with cirrhosis: An external validation in a multi-ethnic population.
Hong-Yi LinPooi Ling LoiJeanette NgLiang ShenWei-Quan TeoAmber ChungPrema RajPik-Eu Jason ChangPublished in: JGH open : an open access journal of gastroenterology and hepatology (2024)
MELD3.0 performs better than MELDNa and MELD in predicting mortality in cirrhotic inpatients. MELD3.0 > 19 predicts higher 30-day mortality.